Interestingly, our results from in vivo blocking assays using 4-IPP, MIF inhibitor and stattic, p-STAT3 inhibitor clearly demonstrated that sizes of tumor from the 4-IPP and stattic injection groups are significantly reduced compared to the control group (Fig. 7). The gene discussed is MIF; the disease is neoplasm.